Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 2,376-2,400 of 3,186
CompletedNCT05643196

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
CompletedNCT03526354

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

This study exists to see whether the medication Brexpiprazole is workable and worth testing more broadly. Researchers are trying to understand whether the medication Brexpiprazole can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Schizophrenia
RecruitingNCT06118268

iTBS to Enhance Social Cognition in People With Psychosis

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 39 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
RecruitingNCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
CompletedNCT05486312

7-week Study With CT-155 in People With Schizophrenia

This study exists to see whether the medication CT-155 can play a useful role in care. Researchers are trying to understand whether the medication CT-155 can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
TerminatedNCT03230097

This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year

This study exists to learn from real-world information that can show how questionnaires and follow-up reports fits into care. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
Canada, China, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
TerminatedNCT03351244

This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Canada, France, Japan, South Korea, Spain, Taiwan, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
RecruitingNCT06386588

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
RecruitingNCT06835556

Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Active Not RecruitingNCT06245213

A Study of ANAVEX3-71 in Adults With Schizophrenia

This study exists to understand whether the medication ANAVEX3-71 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication ANAVEX3-71 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Anavex Life Sciences Corp.
Condition
Schizophrenia
CompletedNCT02431702

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
Brazil, Mexico, United States
Sponsor
Janssen Scientific Affairs, LLC
Condition
Schizophrenia
CompletedNCT03345342

A Study of Paliperidone Palmitate 6-Month Formulation

This study exists to explore whether the medication Paliperidone could improve care and understanding. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Argentina, Australia, Brazil, Bulgaria, Czech Republic, France, China, Hungary, India, Italy, Malaysia, Mexico, Poland, Russian Federation, South Africa, South Korea, Spain, Taiwan, Turkey, Ukraine, United States
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
CompletedNCT03571685

Sustainable Early Episode Clinic Study (SEEC)

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Janssen Scientific Affairs, LLC
Condition
Schizophrenia
RecruitingNCT05284721

Family Peer Navigator for Early Psychosis for Black Families

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Washington State University
Condition
Schizophrenia
RecruitingNCT02455193

Neuronal Effects of Exercise in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 21 Years to 70 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Schizophrenia
TerminatedNCT03220438

TMS Enhancement of Visual Plasticity in Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Not Yet RecruitingNCT06923891

An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Vanguard Research Group
Condition
Schizophrenia
Not Yet RecruitingNCT06924255

An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Collaborative Neuroscience Research, LLC
Condition
Schizophrenia
CompletedNCT00688259

Cognitive-Behavioral Therapy in Veterans With Schizophrenia

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
TerminatedNCT05462340

PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Schizophrenia
CompletedNCT06572449

Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
CompletedNCT06107803

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
CompletedNCT03245437

Target Engagement and Response to Oxytocin

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia